₹ 2.7 Cr
Volume Transacted
(Nov 22, 2024)
368.2 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 22, 2024
Morepen Laboratories Ltd
NSE: MOREPENLAB
ISIN
INE083A01026
Last updated on: Nov 22, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Morepen Laboratories Ltd
NSE: MOREPENLAB
Share Price
₹ 74.05
0.84 (1.15%)
Last updated on: Nov 22, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 74.05 | 73.49 | 75.29 | 73.26 |
21 Nov 2024 | 73.21 | 76.64 | 76.64 | 72.79 |
19 Nov 2024 | 75.87 | 75.29 | 76.89 | 74.64 |
18 Nov 2024 | 74.22 | 76.01 | 77.15 | 73.4 |
14 Nov 2024 | 75.62 | 76.02 | 77.6 | 75.25 |
13 Nov 2024 | 75.52 | 79.77 | 79.77 | 75.11 |
12 Nov 2024 | 79.94 | 80.25 | 82.73 | 79.33 |
11 Nov 2024 | 80.26 | 83.99 | 87.32 | 77.52 |
08 Nov 2024 | 83.31 | 85.29 | 86.3 | 83 |
07 Nov 2024 | 84.56 | 86.44 | 87.25 | 84.2 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 74.05 |
21 Nov 2024 | 73.21 |
19 Nov 2024 | 75.87 |
18 Nov 2024 | 74.22 |
14 Nov 2024 | 75.62 |
13 Nov 2024 | 75.52 |
12 Nov 2024 | 79.94 |
11 Nov 2024 | 80.26 |
08 Nov 2024 | 83.31 |
07 Nov 2024 | 84.56 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 22 Nov 15:30 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Morepen Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Morepen Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Morepen Laboratories to discuss results
Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 11 No...
08 Nov 202410:49
Morepen Laboratories schedules AGM
Morepen Laboratories announced that the Annual General Meeting (AGM) of the company will b...
12 Sep 202416:01
Morepen Laboratories appoints director
Morepen Laboratories has appointed Sharad Jain (DIN: 06423452) as an Independent Director,...
27 Aug 202415:31
Morepen Labs soars after stellar Q1 performance
Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period und...
12 Aug 202412:44
Morepen Laboratories to announce Quarterly Result
Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Au...
10 Aug 202416:53
Morepen Laboratories successfully concludes QIP issue of Rs 200 cr
Morepen Laboratories announced the successful subscription of a Qualified Institutional Pl...
06 Aug 202409:09
Unlimited trading at just
Rs. 199*